Tetra Bio-Pharma Inc. (TBPMF) is a biopharmaceutical company dedicated to discovering and advancing cannabinoid-based medications. Its research and development efforts span crucial medical fields, including inflammation, pain management, ophthalmology, and oncology. The company's pipeline features several key drug candidates: PLENITUDE is being developed to address cancer-related pain in advanced-stage patients.